fashion -WSS

fashion

author：Wikipedia 2025-09-30 00:51:36 - browse：51859

Does biotech prepare you for the presidency? Who really wants to gut the FDA? And why do drug companies struggle with IT?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss how Vivek Ramaswamy, fresh off his headline-grabbing debut at the first Republican presidential debate, went from a drug industry entrepreneur to a GOP rising star — and how his former biotech colleagues are reacting to it. We also explain the latest news in the life sciences, including a curious data leak and the family business of a famed biotech inventor.

For more on what we cover, here’s more on Ramaswamy; here’s the news on the data leak; here’s the story on the latest Langer venture; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Hollywood unions extend contract negotiations for actors
Next article： BD to buy Edwards patient monitoring unit for $4.2 billion

WSS

FTC loses bid to block Novant's North Carolina hospital merger

'Little Tech' descents on D.C., wanting a say in how AI is regulated

Anthony Fauci pushes back on GOP claims during Covid hearing

Future doctors should be trained to promote social change

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Future doctors should be trained to promote social change

knowledge

fashion

leisure time

Wildfire smoke exposes gaps in outdoor worker protections

Structure Therapeutics oral GLP

In Memoriam: Notable people who died in 2023

Plastic surgeons increase patient psychiatric screenings

Hollywood unions extend contract negotiations for actors

The most pressing bird flu mysteries scientists want answered

Duchenne breakthrough therapy leaves behind pioneering families

Nurses recount patients attacks

In age of alternative facts, a scholarly course on calling out crap

Illumina board agrees to spin off Grail, as divestment plans proceed

focus

Orchard's therapy for neuron disease in children wins FDA approval

Readout Newsletter: Bluebird, CVS, Contineum

Stopping antidepressants leads to symptoms for 1 in 6 patients

FDA approves Moderna’s RSV vaccine, its second licensed product

Gene editing the human germline: What are the risks?

Data don't support strong claims for Covid

knowledge

Wikipedia

explore

hotspot